Literature DB >> 17497673

Decreased focal inflammatory response by G-CSF may improve stroke outcome after transient middle cerebral artery occlusion in rats.

Yoshihide Sehara1, Takeshi Hayashi, Kentaro Deguchi, Hanzhe Zhang, Atsushi Tsuchiya, Toru Yamashita, Violeta Lukic, Makiko Nagai, Tatsushi Kamiya, Koji Abe.   

Abstract

Recent studies have shown that administration of granulocyte colony-stimulating factor (G-CSF) is neuroprotective. However, the precise mechanisms of the neuroprotective effect of G-CSF are not entirely known. We carried out 90-min transient middle cerebral occlusion (tMCAO) of rats. The rats were injected with vehicle or G-CSF (50 mug/kg) immediately after reperfusion and sacrificed 8, 24, or 72 hr later. 2,3,5-Triphenyltetrazolium chloride (TTC) staining was carried out using brain sections of 72 hr, and immunohistochemistry was carried out with those of 8, 24, and 72 hr. TTC-staining showed a significant reduction of infarct volume in the G-CSF-treated group (**P < 0.01). Immunohistochemistry showed a significant decrease of the number of cells expressing tumor necrosis factor-alpha (TNF-alpha) at 8-72 hr, transforming growth factor-beta (TGF-beta) and inducible nitric oxide synthase (iNOS) at 24 and 72 hr after tMCAO in the peri-ischemic area (*P < 0.05 each). Our data suggest that the suppression of inflammatory cytokines and iNOS expression may be one mechanism of neuroprotection by G-CSF. (c) 2007 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17497673     DOI: 10.1002/jnr.21341

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN: 0360-4012            Impact factor:   4.164


  22 in total

Review 1.  Stem cell therapy for cerebral ischemia: from basic science to clinical applications.

Authors:  Koji Abe; Toru Yamashita; Shunya Takizawa; Satoshi Kuroda; Hiroyuki Kinouchi; Nobutaka Kawahara
Journal:  J Cereb Blood Flow Metab       Date:  2012-01-18       Impact factor: 6.200

2.  Future Perspectives for Brain Pharmacotherapies: Implications of Drug Transport Processes at the Blood-brain Barrier.

Authors:  Dirk M Hermann
Journal:  Ther Adv Neurol Disord       Date:  2008-11       Impact factor: 6.570

Review 3.  Stem cells and G-CSF for treating neuroinflammation in traumatic brain injury: aging as a comorbidity factor.

Authors:  I Dela Peña; P R Sanberg; S Acosta; N Tajiri; S Z Lin; C V Borlongan
Journal:  J Neurosurg Sci       Date:  2014-05-20       Impact factor: 2.279

4.  G-CSF administration is neuroprotective following transient cerebral ischemia even in the absence of a functional NOS-2 gene.

Authors:  Claire L Gibson; Philip M W Bath; Sean P Murphy
Journal:  J Cereb Blood Flow Metab       Date:  2010-02-10       Impact factor: 6.200

Review 5.  Investigational therapies for ischemic stroke: neuroprotection and neurorecovery.

Authors:  Preeti Sahota; Sean I Savitz
Journal:  Neurotherapeutics       Date:  2011-07       Impact factor: 7.620

6.  Granulocyte Colony Stimulating Factor Enhances Reward Learning through Potentiation of Mesolimbic Dopamine System Function.

Authors:  Munir Gunes Kutlu; Lillian J Brady; Emily G Peck; Rebecca S Hofford; Jordan T Yorgason; Cody A Siciliano; Drew D Kiraly; Erin S Calipari
Journal:  J Neurosci       Date:  2018-08-27       Impact factor: 6.167

7.  Implications of immune system in stroke for novel therapeutic approaches.

Authors:  Aaron A Hall; Keith R Pennypacker
Journal:  Transl Stroke Res       Date:  2010-01-13       Impact factor: 6.829

8.  Acute kidney injury leads to inflammation and functional changes in the brain.

Authors:  Manchang Liu; Yideng Liang; Srinivasulu Chigurupati; Justin D Lathia; Mikhail Pletnikov; Zhaoli Sun; Michael Crow; Christopher A Ross; Mark P Mattson; Hamid Rabb
Journal:  J Am Soc Nephrol       Date:  2008-04-02       Impact factor: 10.121

Review 9.  Organ cross talk and remote organ damage following acute kidney injury.

Authors:  Rele Ologunde; Hailin Zhao; Kaizhi Lu; Daqing Ma
Journal:  Int Urol Nephrol       Date:  2014-06-26       Impact factor: 2.370

10.  Stroke-associated infection independently predicts 3-month poor functional outcome and mortality.

Authors:  Satoshi Suda; Junya Aoki; Takashi Shimoyama; Kentaro Suzuki; Yuki Sakamoto; Takehiro Katano; Seiji Okubo; Chikako Nito; Yasuhiro Nishiyama; Masahiro Mishina; Kazumi Kimura
Journal:  J Neurol       Date:  2017-12-16       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.